1Debing Y, Neyts J. Antiviral strategies for hepatitis E virus [J]. Antiviral Res, 2014, 102: 106-118. DOI: 10. 1016/j. antiviral. 2013.12. 005.
2Balayan MS, Andjaparidze AG, Savinskaya SS,et al. Evidence for a virus in non A, non B hepatitis transmitted via the fecaloral route [J]. Intervirology, 1983,20(1):23-31.
3Boxall E, Herborn A, Kochethu G, et al. Transfusion- transmitted hepatitis E in a 'nonhyperendemic' country [J]. Transfus Med, 2006, 16 (2): 79-83. DOI: 10. 1111/j. 1365- 3148. 2006. 00652. x.
4Colson P, Coze C, Gallian P, et al. Transfusion-associated hepatitis E, France [J]. Emerg Infect Dis, 2007,13(4):648- 649. DOI: 10. 3201/eid1304. 061387.
5Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus [J]. Lancet, 1995,345(8956) : 1025-1026.
6Davern TJ, Chalasani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury [J]. Gastroenterology, 2011,141 (5) : 1665-1672. e1-9. DOI: 10. 1053/j. gastro. 2011.07. 051.
7Kamar N, Mansuy JM, Cointault O,et al. Hepatitis E virus related cirrhosis in kidneF and kidney-pancreas-transplant recipients [J]. Am J Transplant, 2008, 8 (8): 1744-1748. DOI: 10. 1111/j. 1600-6143. 2008.
8Kamar N, Selves J, Mansuy JM,et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients [J]. N Engl J Med, 2008, 858 ( 8 ): 811-817. DOI: 10. 1056/ N[JMoa0706992.
9Kamar N, Weclawiak H, Guilbeau Frugier C, et al. Hepatitis E virus and the kidney in solid-organ transplant patients [J]. Transplantation, 2012, 93 (6):617-623. DOI: 10. 1097/TP. 0b013e318245f14c.
10Kamar N, Garrouste C, Haagsma EB,et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants [J]. Gastroenterology, 2011,140(5) : 1481-1489. DOI: 10. 1053/j. gastro. 2011. 02. 050.
